新冠肺炎患者循环促凝磷脂增加的证据及其预后作用。 - Suppr | 超能文献

相似文献

1

Evidence for increased circulating procoagulant phospholipids in patients with COVID-19 pneumonia and their prognostic role.新冠肺炎患者循环促凝磷脂增加的证据及其预后作用。

Clin Chem Lab Med. 2020 Oct 29;59(2):e53-e55. doi: 10.1515/cclm-2020-1260.

2

Coagulation abnormalities and thrombosis in patients with COVID-19.新型冠状病毒肺炎患者的凝血异常与血栓形成

Lancet Haematol. 2020 Jun;7(6):e438-e440. doi: 10.1016/S2352-3026(20)30145-9. Epub 2020 May 11.

3

Fatal Disseminated Intravascular Coagulopathy in Covid-19: A Small Case Series.新型冠状病毒肺炎相关的致死性弥散性血管内凝血：一项小型病例系列研究

Semin Thromb Hemost. 2021 Jun;47(4):427-430. doi: 10.1055/s-0040-1716871. Epub 2020 Dec 17.

4

e-Thrombosis in the COVID-19 era: collateral effects of confinement.新冠疫情时代的电子血栓形成：隔离的附带影响

Med Intensiva (Engl Ed). 2021 Mar;45(2):122-124. doi: 10.1016/j.medin.2020.08.003. Epub 2020 Sep 4.

5

Risk Benefit Analysis in Reference to use of LMWH in COVID-19.关于在2019冠状病毒病中使用低分子肝素的风险效益分析。

J Assoc Physicians India. 2020 Sep;68(9):52-61.

6

High rates of pulmonary artery occlusions in COVID-19. A meta-analysis.COVID-19 患者肺动脉闭塞发生率较高。一项荟萃分析。

Eur J Clin Invest. 2021 Jan;51(1):e13433. doi: 10.1111/eci.13433. Epub 2020 Oct 31.

7

[Acute venous thrombosis: new directions in prophylaxis and treatment].[急性静脉血栓形成：预防与治疗的新方向]

Khirurgiia (Mosk). 1998(12):60-3.

8

The Potential of Low Molecular Weight Heparin to Mitigate Cytokine Storm in Severe COVID-19 Patients: A Retrospective Cohort Study.低分子量肝素减轻重症 COVID-19 患者细胞因子风暴的潜力：一项回顾性队列研究。

Clin Transl Sci. 2020 Nov;13(6):1087-1095. doi: 10.1111/cts.12880. Epub 2020 Oct 15.

9

[Treatment guidelines for deep venous thrombosis and pulmonary embolus].[深静脉血栓形成和肺栓塞的治疗指南]

Duodecim. 2001;117(24):2603-10.

10

Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines.COVID-19 相关静脉血栓栓塞症：已报告风险和现行指南的系统综述。

Swiss Med Wkly. 2020 Jun 21;150:w20301. doi: 10.4414/smw.2020.20301. eCollection 2020 Jun 15.

引用本文的文献

1

Extracellular histones: a unifying mechanism driving platelet-dependent extracellular vesicle release and thrombus formation in COVID-19.细胞外组蛋白：驱动 COVID-19 中血小板依赖性细胞外囊泡释放和血栓形成的统一机制。

J Thromb Haemost. 2024 Sep;22(9):2514-2530. doi: 10.1016/j.jtha.2024.05.019. Epub 2024 May 28.

2

Extracellular Vesicles: New Players in the Mechanisms of Sepsis- and COVID-19-Related Thromboinflammation.细胞外囊泡：脓毒症和 COVID-19 相关血栓炎症机制中的新角色。

Int J Mol Sci. 2023 Jan 18;24(3):1920. doi: 10.3390/ijms24031920.

3

A systematic review of biomarkers among hospitalized patients with COVID-19 predictive of venous thromboembolism: A communication from the Predictive and Diagnostic Variables Scientific and Standardization Committee of the ISTH.